Kennedy Giulia C's Form 4 filing
Veracyte, Inc. (VCYT) · filed Dec 8, 2021
- Accession no.
- 0001384101-21-000180
- Filed
- Dec 8, 2021
- Trade date
- Dec 6-7, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 9 non-derivative transactions and 4 derivative transactions. Open-market sales total $579.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kennedy Giulia CCIK 0001769333 | Officer (Chief Scientific & Med Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 6, 2021 | Common Stock | MOption exerciseAcquired | +4,406 | $5.98 | +$26,347.88 | 53,394 | Direct | |
| Dec 6, 2021 | Common Stock | MOption exerciseAcquired | +3,750 | $20.21 | +$75,787.5 | 57,144 | Direct | |
| Dec 6, 2021 | Common Stock | SSaleDisposed | −3,550 | $35.37F2 | −$125,563.5 | 53,594 | Direct | |
| Dec 6, 2021 | Common Stock | SSaleDisposed | −3,897 | $36.11F3 | −$140,720.67 | 49,697 | Direct | |
| Dec 6, 2021 | Common Stock | SSaleDisposed | −1,785 | $37.26F4 | −$66,509.1 | 47,912 | Direct | |
| Dec 7, 2021 | Common Stock | MOption exerciseAcquired | +4,375 | $24.69 | +$108,018.75 | 52,287 | Direct | |
| Dec 7, 2021 | Common Stock | MOption exerciseAcquired | +1,750 | $26.55 | +$46,462.5 | 54,037 | Direct | |
| Dec 7, 2021 | Common Stock | SSaleDisposed | −4,375 | $39.69 | −$173,643.75 | 49,662 | Direct | |
| Dec 7, 2021 | Common Stock | SSaleDisposed | −1,750 | $41.55 | −$72,712.5 | 47,912 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 6, 2021 | Common Stock | MOption exerciseDisposed | −4,406 | $0.00 | $0 | 4,407 | Direct | |
| Dec 6, 2021 | Common Stock | MOption exerciseDisposed | −3,750 | $0.00 | $0 | 18,750 | Direct | |
| Dec 7, 2021 | Common Stock | MOption exerciseDisposed | −4,375 | $24.69 | −$108,018.75 | 39,375 | Direct | |
| Dec 7, 2021 | Common Stock | MOption exerciseDisposed | −1,750 | $26.55 | −$46,462.5 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents weighted average sales price. Sale prices for the transactions range from $34.70 to $35.70. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Referenced by the price of 1 transaction in Table I.
- F3
Represents weighted average sales price. Sale prices for the transactions range from $35.79 to $36.74. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Referenced by the price of 1 transaction in Table I.
- F4
Represents weighted average sales price. Sale prices for the transactions range from $36.88 to $37.66. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Referenced by the price of 1 transaction in Table I.